(Q40589232)

21 September 2017

title

Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children (English)

1 reference

sulfamethoxazole/trimethoprim

21 September 2017

0 references

0 references

0 references

1 reference

Omar SA

1

1 reference

21 September 2017

Bakari A

2

1 reference

21 September 2017

Owiti A

3

1 reference

21 September 2017

Adagu IS

4

1 reference

21 September 2017

Warhurst DC

5

1 reference

21 September 2017

language of work or name

1 reference

1 November 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

21 September 2017

published in

1 reference

21 September 2017

volume

95

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

657-660

1 reference

Co-trimoxazole for childhood febrile illness in malaria-endemic regions

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

TRIAL OF CO-TRIMOXAZOLE VERSUS PROCAINE PENICILLIN WITH AMPICILLIN IN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN YOUNG GAMBIAN CHILDREN

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990107-5

7 January 2021

10.1016/S0035-9203(01)90107-5

Identifiers

DOI

1 reference

21 September 2017

1 reference